Total Return chart Celltrion, Inc.

Stocks

End-of-day quote Korea S.E. Other stock markets 14/07/2026			5-day change	1st Jan Change
1,72,800.00 ^KRW	-1.31%		-3.03%	+0.24%

14/07	Celltrion Terminates, Withdraws EMA Trial Application for CT-P51 Biosimilar	MT
07/07	Celltrion Submits Amendment for Phase 3 Trial of Cancer Biosimilar to US FDA	MT

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.